F
FineHeart
Biotech & Life Sciences · Pessac, France · Founded 2010
A French medical device company focused on creating innovative technologies in the cardiovascular space MoreLess
Developer of implantable cardiac devices designed to treat cardiovascular diseases. The company's device is a novel, wirelessly powered, fully implantable mechanical circulatory support device that is able to optimize cardiac output while preserving the heart's innate contractility, enabling patients to restore normal cardiac output and allow heart failure patients to return to a normal quality of life. Keywords: Healthcare Devices, Services, Supplies, Cardiac Output, Cardiac Output Management, Cardiovascular Device, Circulatory Support Device, Heart Disease Therapy, Implantables Device, Mechatronic Medicine, Output Management System.
Company overview
FineHeart company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2010
- Headquarters
- Pessac, France
- Employees
- 87
- Open positions
- None listed
- Dealroom signal
- 79.7
Valuation & funding
FineHeart funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Jan 2026 | $39M | $154M | Groupe Pasteur Mutualité · NACo · EIC Fund · Irdi Capital Investissement | ↗ |
| GRANTOther financing | Dec 2024 | $825K | — | European Regional Development Fund | ↗ |
| GRANTOther financing | Mar 2024 | $8.6M | — | France 2030 | ↗ |
| GRANTOther financing | Jun 2022 | $2.5M | — | European Innovation Council | — |
| EARLY VCOther financing | Jun 2022 | $0 | — | EIC Fund | — |
| SERIES BOther financing | Dec 2021 | Undisclosed | ↗ | ||
| SERIES BOther financing | Jun 2021 | Aqui-Invest · Galia Gestion · IRDInov · Lauak Évora | — | ||
| SERIES AOther financing | Mar 2016 | Sofimac Régions · Aqui-Invest · Broadview Ventures · M Capital Partners | ↗ | ||
| SUPPORT PROGRAMOther financing | Feb 2004 | HEC Paris · HEC Challenge+ | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | EBITDA | Margin |
|---|---|---|---|---|
| 2026 | $0 | — | −$2.9M | — |
| 2025 | $0 | — | −$2.9M | — |
| 2024 | $0 | — | −$2.9M | — |
| 2023 | $0 | — | −$2.9M | — |
| 2022 | $0 | — | −$2.9M | — |
| 2021 | $0 | — | −$2.9M | — |
| 2020 | $0 | — | −$2.9M | — |
Growth signals
FineHeart website traffic
Latest recorded traffic for FineHeart is 480 monthly website visits, down 31.4% over the last three months. FineHeart's team grew 1.2% over the past year.
Comparisons
FineHeart compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
FineHeart's talent
Source: Dealroom Talent Intelligence.
Investors
20 investors on FineHeart's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where FineHeart has talent and traffic
team presence
In the news
Latest news about FineHeart
Recent press, funding announcements, and product moves mentioning FineHeart — open to read from the original sources.
Market sentiment
What the market is saying about FineHeart
An AI-synthesized read of the highest-engagement posts about FineHeart on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See FineHeart’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.